NKX2-4

gene
On this page

Also known as NKX2.4

Summary

NKX2-4 (NK2 homeobox 4, HGNC:7837) is a protein-coding gene on chromosome 20p11.22, encoding Homeobox protein Nkx-2.4 (Q9H2Z4). Probable transcription factor.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in cell differentiation and regulation of transcription by RNA polymerase II. Predicted to be located in chromatin. Predicted to be active in nucleus.

Source: NCBI Gene 644524 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 80 total — 1 pathogenic
  • MANE Select transcript: NM_033176

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:7837
Approved symbolNKX2-4
NameNK2 homeobox 4
Location20p11.22
Locus typegene with protein product
StatusApproved
AliasesNKX2.4
Ensembl geneENSG00000125816
Ensembl biotypeprotein_coding
OMIM607808
Entrez644524

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000351817

RefSeq mRNA: 1 — MANE Select: NM_033176 NM_033176

CCDS: CCDS42855

Canonical transcript exons

ENST00000351817 — 2 exons

ExonStartEnd
ENSE000013656472139695821397526
ENSE000014729302139536521396533

Expression profiles

Bgee: expression breadth broad, 12 present calls, max score 84.32.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1677 / max 48.6944, expressed in 31 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1866010.106527
1866000.061223

Top tissues by expression

128 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099184.32gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047382.99gold quality
right testisUBERON:000453449.26gold quality
testisUBERON:000047348.77gold quality
left testisUBERON:000453348.27gold quality
hypothalamusUBERON:000189843.61gold quality
ventricular zoneUBERON:000305340.13gold quality
bone marrow cellCL:000209239.99gold quality
colonic epitheliumUBERON:000039737.20gold quality
cortical plateUBERON:000534336.47gold quality
adenohypophysisUBERON:000219636.39gold quality
ganglionic eminenceUBERON:000402335.49gold quality
granulocyteCL:000009435.31gold quality
bone marrowUBERON:000237133.70gold quality
pituitary glandUBERON:000000733.40gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
prefrontal cortexUBERON:000045131.29gold quality
muscle tissueUBERON:000238531.06gold quality
sural nerveUBERON:001548830.93gold quality
primary visual cortexUBERON:000243630.57gold quality
C1 segment of cervical spinal cordUBERON:000646930.22silver quality
superior frontal gyrusUBERON:000266129.94gold quality
stromal cell of endometriumCL:000225529.87gold quality
leukocyteCL:000073829.68gold quality
liverUBERON:000210729.46gold quality
monocyteCL:000057629.33gold quality
placentaUBERON:000198729.28gold quality
substantia nigraUBERON:000203828.74gold quality
duodenumUBERON:000211428.14gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.00

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA2003.1NKX2-4NK
MA2003.2NKX2-4NK

JASPAR matrix evidence (PMIDs): PMID:18585359

miRNA regulators (miRDB)

32 targeting NKX2-4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-150-5P99.9966.691976
HSA-MIR-25-3P99.9874.601817
HSA-MIR-32-5P99.9875.211964
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-4694-3P99.7969.532640
HSA-MIR-4713-5P99.7867.801794
HSA-MIR-320A-3P99.7769.732107
HSA-MIR-320B99.7769.732107
HSA-MIR-320C99.7769.732107
HSA-MIR-320D99.7769.732107
HSA-MIR-442999.7769.622111
HSA-MIR-5197-5P99.6469.081494
HSA-MIR-409-3P99.5066.331192
HSA-MIR-432599.4972.201342
HSA-MIR-20B-3P99.2967.05784
HSA-MIR-224-3P98.9168.421815
HSA-MIR-522-3P98.9168.561817
HSA-MIR-6780A-3P98.4267.491518
HSA-MIR-6509-3P98.3267.331343
HSA-MIR-6881-3P98.0468.241777
HSA-MIR-392197.8167.451431
HSA-MIR-7111-3P97.8066.751467
HSA-MIR-770397.6467.00965
HSA-MIR-320E97.4965.96865
HSA-MIR-4653-5P97.2267.721429
HSA-MIR-4445-5P97.2166.16832
HSA-MIR-4436B-5P96.7168.371346

Literature-anchored findings (GeneRIF, showing 2)

  • NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML. (PMID:34768865)
  • Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor. (PMID:36459980)

Cross-species orthologs

11 orthologs

OrganismSymbolGene ID
danio_rerionkx2.4aENSDARG00000075107
danio_rerionkx2.4bENSDARG00000104107
mus_musculusNkx2-4ENSMUSG00000054160
rattus_norvegicusNkx2-4ENSRNOG00000012647
drosophila_melanogasterNK7.1FBGN0024321
drosophila_melanogasterHGTXFBGN0040318
drosophila_melanogasterscroFBGN0287186
caenorhabditis_elegansceh-9WBGENE00000434
caenorhabditis_elegansWBGENE00000447
caenorhabditis_elegansWBGENE00000450
caenorhabditis_elegansWBGENE00000584

Paralogs (13): NKX3-2 (ENSG00000109705), NKX2-3 (ENSG00000119919), NKX2-2 (ENSG00000125820), NKX2-8 (ENSG00000136327), NKX2-1 (ENSG00000136352), NKX6-2 (ENSG00000148826), NKX6-1 (ENSG00000163623), NKX6-3 (ENSG00000165066), NKX3-1 (ENSG00000167034), NKX2-6 (ENSG00000180053), NKX2-5 (ENSG00000183072), NKX1-2 (ENSG00000229544), NKX1-1 (ENSG00000235608)

Protein

Protein identifiers

Homeobox protein Nkx-2.4Q9H2Z4 (reviewed: Q9H2Z4)

Alternative names: Homeobox protein NK-2 homolog D

All UniProt accessions (1): Q9H2Z4

UniProt curated annotations — full annotation on UniProt →

Function. Probable transcription factor.

Subcellular location. Nucleus.

Similarity. Belongs to the NK-2 homeobox family.

RefSeq proteins (1): NP_149416* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001356HDDomain
IPR009057Homeodomain-like_sfHomologous_superfamily
IPR017970Homeobox_CSConserved_site
IPR020479HD_metazoaDomain
IPR050394Homeobox_NK-likeFamily

Pfam: PF00046

UniProt features (6 total): sequence conflict 2, chain 1, DNA-binding region 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H2Z4-F159.610.20

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 36 (showing top): chr20p11, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MEISSNER_BRAIN_HCP_WITH_H3K27ME3, MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3, MIKKELSEN_MCV6_HCP_WITH_H3K27ME3, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX7_TARGET_GENES, MIR32_5P, MIR92A_3P, MIR92B_3P, MIR367_3P, MIR363_3P, MIR25_3P, MIR4325

GO Biological Process (5): regulation of transcription by RNA polymerase II (GO:0006357), cell differentiation (GO:0030154), positive regulation of transcription by RNA polymerase II (GO:0045944), animal organ development (GO:0048513), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515)

GO Cellular Component (2): chromatin (GO:0000785), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
transcription by RNA polymerase II2
regulation of transcription by RNA polymerase II2
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
transcription cis-regulatory region binding2
cellular developmental process1
positive regulation of DNA-templated transcription1
anatomical structure development1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
nucleic acid binding1
transcription regulator activity1
binding1
chromosome1
cellular anatomical structure1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

594 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
NKX2-4DCUN1D1Q96GG9900
NKX2-4C8orf74Q6P047543
NKX2-4KIZQ2M2Z5507
NKX2-4XRN2Q9H0D6445
NKX2-4NKX2-2O95096381
NKX2-4FOXB2Q5VYV0367
NKX2-4SFTPBP07988354
NKX2-4PAX1P15863351
NKX2-4ZNF300Q96RE9348
NKX2-4KAT14Q9H8E8347
NKX2-4NKX6-3A6NJ46346
NKX2-4LMX1BO60663346
NKX2-4CRNKL1Q9BZJ0343
NKX2-4LHX6Q9UPM6342
NKX2-4IRX3P78415329

IntAct

14 interactions, top by confidence:

ABTypeScore
NOTONKX2-4psi-mi:“MI:0915”(physical association)0.560
ETV7NFIBpsi-mi:“MI:2364”(proximity)0.470
NKX2-5psi-mi:“MI:0914”(association)0.350
AIM2DDX39Apsi-mi:“MI:0914”(association)0.350
ARGLU1PIAS2psi-mi:“MI:2364”(proximity)0.270
NFIBBCL9psi-mi:“MI:2364”(proximity)0.270
PAX2BCL9psi-mi:“MI:2364”(proximity)0.270
PAX8BCL9psi-mi:“MI:2364”(proximity)0.270
SOX17BCL9psi-mi:“MI:2364”(proximity)0.270
SP7IGF2BP3psi-mi:“MI:2364”(proximity)0.270
TBR1BCL9psi-mi:“MI:2364”(proximity)0.270
NKX2-4NOTOpsi-mi:“MI:0915”(physical association)0.000

BioGRID (16): NOTO (Two-hybrid), NKX2-4 (Affinity Capture-MS), NKX2-4 (Affinity Capture-MS), NKX2-4 (Affinity Capture-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Affinity Capture-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS), NKX2-4 (Proximity Label-MS)

ESM2 similar proteins: A1YER7, A1YF08, A1YFD8, A1YFY3, A1YG85, A2D4P8, A2D4R4, A2D5I1, A2D649, A2T6H5, A2T6X6, A2T6Z0, A2T756, A2T7H5, A2T7J2, O35767, O43186, O88470, P06798, P09016, P10284, P10628, P17277, P17483, P18111, P23813, P31260, P31277, P31310, P42582, P43241, P43345, P47902, P52945, P52946, P52947, P52952, P57073, P58012, P70118

Diamond homologs: A1YF16, A1YG93, A2RU54, A2T764, A6NCS4, A6NHT5, G5EE18, O02786, O15522, O17319, O35767, O43763, O57601, O70218, O70584, O93590, O95096, P13297, P22711, P22808, P22809, P23410, P23441, P28360, P28361, P28362, P35548, P35993, P40764, P41936, P42581, P42582, P42583, P42584, P42586, P42587, P43687, P43688, P43697, P43698

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

80 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance76
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
3068496NC_000020.10:g.19434987_22528253delPathogenic

SpliceAI

210 predictions. Top by Δscore:

VariantEffectΔscore
20:21396956:A:ACdonor_gain0.9900
20:21396957:C:CCdonor_gain0.9900
20:21396959:TG:Tdonor_gain0.9800
20:21396957:CTTGA:Cdonor_gain0.9700
20:21396534:C:CCacceptor_gain0.9500
20:21396532:GACT:Gacceptor_gain0.9400
20:21396533:ACTG:Aacceptor_gain0.9400
20:21396531:AGAC:Aacceptor_gain0.9300
20:21396530:GAGAC:Gacceptor_gain0.9200
20:21396534:CTGG:Cacceptor_gain0.9200
20:21396532:GA:Gacceptor_gain0.8800
20:21396535:T:Aacceptor_gain0.8800
20:21396529:GGAGA:Gacceptor_gain0.8600
20:21396950:CCTCT:Cdonor_loss0.8500
20:21396951:CTCTC:Cdonor_loss0.8500
20:21396952:TCTCA:Tdonor_loss0.8500
20:21396953:CTCAC:Cdonor_loss0.8500
20:21396954:T:TAdonor_loss0.8500
20:21396955:C:CCdonor_loss0.8500
20:21396956:ACT:Adonor_loss0.8500
20:21396957:C:CGdonor_loss0.8500
20:21397023:T:TAdonor_gain0.8500
20:21396533:AC:Aacceptor_loss0.8300
20:21396534:C:Aacceptor_loss0.8300
20:21396535:T:Cacceptor_loss0.8300
20:21396530:GAGA:Gacceptor_gain0.8100
20:21397324:T:TAdonor_gain0.8100
20:21396548:C:Tacceptor_gain0.7900
20:21396968:G:Cdonor_gain0.7900
20:21396536:G:Cacceptor_loss0.7700

AlphaMissense

2250 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
20:21396241:T:AK245N1.000
20:21396241:T:GK245N1.000
20:21396242:T:AK245I1.000
20:21396243:T:CK245E1.000
20:21396247:C:AK243N1.000
20:21396247:C:GK243N1.000
20:21396248:T:AK243M1.000
20:21396248:T:GK243T1.000
20:21396249:T:CK243E1.000
20:21396249:T:GK243Q1.000
20:21396251:T:CY242C1.000
20:21396252:A:CY242D1.000
20:21396252:A:GY242H1.000
20:21396254:C:GR241P1.000
20:21396254:C:TR241Q1.000
20:21396255:G:AR241W1.000
20:21396255:G:CR241G1.000
20:21396257:T:GH240P1.000
20:21396258:G:CH240D1.000
20:21396258:G:TH240N1.000
20:21396259:G:CN239K1.000
20:21396259:G:TN239K1.000
20:21396260:T:AN239I1.000
20:21396260:T:CN239S1.000
20:21396260:T:GN239T1.000
20:21396261:T:CN239D1.000
20:21396261:T:GN239H1.000
20:21396262:C:AQ238H1.000
20:21396262:C:GQ238H1.000
20:21396263:T:CQ238R1.000

dbSNP variants (sampled 300 via entrez): RS1000412367 (20:21396419 G>A,T), RS1000786079 (20:21395743 C>G,T), RS1002070964 (20:21399204 C>A), RS1002138717 (20:21397782 C>T), RS1004294591 (20:21397965 G>C), RS1004304488 (20:21397130 GGCC>G,GGCCGCC,GGCCGCCGCC), RS1004578699 (20:21395531 T>C), RS1004631099 (20:21395230 T>A), RS1005939756 (20:21398051 T>C), RS1006052606 (20:21397261 C>A,T), RS1006695680 (20:21395355 A>G), RS1007414763 (20:21398622 C>T), RS1007666168 (20:21395121 A>G), RS1007881249 (20:21398315 T>C), RS1008220612 (20:21397486 AGCTGAG>A)

Disease associations

OMIM: gene MIM:607808 | disease phenotypes: MIM:256450

GenCC curated gene-disease

Mondo (1): hyperinsulinemic hypoglycemia, familial, 1 (MONDO:0009734)

Orphanet (2): Autosomal dominant hyperinsulinism due to SUR1 deficiency (Orphanet:276575), Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency (Orphanet:276598)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST002479_15Lupus nephritis in systemic lupus erythematosus5.000000e-06
GCST007556_21Autism spectrum disorder3.000000e-07
GCST009391_521Metabolite levels4.000000e-06
GCST010988_318Adult body size8.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010117pyruvate measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
FR900359increases phosphorylation1
butyraldehydeincreases expression1
abrineincreases expression1
Benzo(a)pyrenedecreases methylation1
Cadmiumincreases expression1
Valproic Acidincreases methylation1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.